Table 1.
Characteristics of the study population.
Subject | Age (years) | Sex | Ethnicity | Illness day | IVIG treatment response | CA status | rs28493229 genotype |
---|---|---|---|---|---|---|---|
1 | 0.67 | M | Hispanic | 4 | Responder | Dilated | GG |
2 | 2 | F | Filipino | 8 | Responder | Normal | GG |
3 | 4.3 | M | Caucasian | 6 | Responder | Normal | GG |
4 | 4.9 | M | Filipino/Japanese | 25 | Late treatment | Dilated | GG |
5 | 2.5 | M | Hispanic/Filipino/Caucasian | 5 | Resistant | Dilated | GG |
6 | 2.1 | M | Hispanic | 4 | Responder | Normal | GC |
Illness Day 1 was considered to be the first day of fever. Resistance to IVIG was define as persistent of recrudescent fever at least 36 hours after the completion of the initial IVIG infusion. Coronary artery status was determined by transthoracic echocardiography. Patients were considered to have dilated coronary arteries if the CA Z score for either the right or left anterior descending coronary arteries was ≥ 2.0 and returned to normal dimensions within 2 months after illness onset.